Article

Identification of Potential Drug Targets and Prediction of the Potential Impact of High Risk Non Synonymous Single Nucleotide Polymorphism in SARS-CoV-2 3C like Proteinase (3CLpro): A Computational Approach

2020-05-05

Abstract excerpt

On January 2020, a new coronavirus (officially named SARS-CoV-2) was associated with alarming outbreak of a pneumonia-like illness, which was later named by the WHO as COVID-19, originating from Wuhan City, China. Although many clinical studies involving antiviral and immunomodulatory drug treatments for SARS-CoV-2 all without reported results, no approved drugs have been found to effectively inhibit the virus so...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d3b58ac5-3ad3-53dc-899c-ea12021c0c67
DOI: 10.26434/chemrxiv.12235181.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Potential Drug Targets and Prediction of the Potential Impact of High Risk Non Synonymous Single Nucleotide Polymorphism in SARS-CoV-2 3C like Proteinase (3CLpro): A Computational ApproachDOI 10.26434/chemrxiv.12235181.v1Read

A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposingSemantic proximity Read

A Comprehensive SARS-CoV-2 Genomic Analysis Identifies Potential Targets for Drug RepurposingSemantic proximity Read

Sequence characterization and molecular modeling of clinically relevant variants of the SARS-CoV-2 main proteaseSemantic proximity Read

Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug bindingSemantic proximity Read

Genetic Variability of the SARS-CoV-2 PocketomeSemantic proximity Read

Structural Differences In 3C-like protease (Mpro) From SARS-CoV and SARS-CoV-2: Molecular Insights For Drug Repurposing Against COVID-19 Revealed by Molecular Dynamics SimulationsSemantic proximity Read

Sequence Characterization and Molecular Modeling of Clinically Relevant Variants of the SARS-CoV-2 Main Protease.Semantic proximity Read

Structure-Based Virtual Screening to Discover Potential Lead Molecules for the SARS-CoV‑2 Main ProteaseSemantic proximity Read

Whole Genome Sequence Analysis and Homology Modelling of a 3C Like Peptidase and a Non-Structural Protein 3 of the SARS-CoV-2 Shows Protein Ligand Interaction with an Aza-Peptide and a Noncovalent Lead Inhibitor with Possible Antiviral PropertiesSemantic proximity Read

Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach**Semantic proximity Read

Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screeningSemantic proximity Read

Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 ManagementSemantic proximity Read